D-1473-2022 Class II Terminated

Recalled by Teva Pharmaceuticals USA Inc — Parsippany, NJ

Recall Details

Product Type
Drugs
Report Date
September 7, 2022
Initiation Date
August 23, 2022
Termination Date
September 7, 2023
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity

Product Description

Neomycin Sulfate Tablets, USP 500 mg , 100-count bottles, Rx only, Distributed by: TEVA PHARMACEUTICALS USA, INC North Wales, PA 19454, NDC 0093-1177-01

Reason for Recall

CGMP Deviations: A foreign matter identified as teflon was found in the Active Pharmaceutical Ingredient (API) used in the manufacture of Neomycin Sulfate Tablets, USP 500 mg.

Distribution Pattern

Nationwide within the United States

Code Information

Lot #: 3007830, 3007746, 3007829, Exp. Date 10/2024